Davis Todd C - Insider Non-Derivative Transactions at LIGAND PHARMACEUTICALS INC (LGND) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 8, 2024, Davis Todd C's relationship to LIGAND PHARMACEUTICALS INC (LGND) is Director,Officer (Chief Executive Officer), and currently has 123,010 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LGND insiders.
Data Source: SEC.
Davis Todd C - Insider Non-Derivative Transactions of LGND Common Stock
Davis Todd C - Insider Non-Derivative Transactions at LGND
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 9, 2024 | P -- (Common Stock) | 2500 | 97.39 | 123010 |
| Jun 29, 2024 | J -- (Common Stock) | 350 | 60.71 | 120510 |
| Mar 26, 2024 | M -- (Common Stock) | 7448 | 46.2 | 111593 |
| Mar 26, 2024 | M -- (Common Stock) | 2855 | 67.24 | 114448 |
| Mar 26, 2024 | M -- (Common Stock) | 2156 | 68.51 | 116604 |
| Mar 26, 2024 | M -- (Common Stock) | 3556 | 66.19 | 120160 |
| Feb 28, 2024 | Acquisition -- (Common Stock) | 32436 | 0 | 104145 |
| Feb 16, 2024 | F -- (Common Stock) | 1381 | 74.65 | 71709 |
| Sep 23, 2023 | P -- (Common Stock) | 4000 | 59.38 | 73090 |
| Jun 10, 2023 | F -- (Common Stock) | 420 | 73.76 | 69090 |
| Feb 24, 2023 | Acquisition -- (Common Stock) | 17005 | 0 | 68791 |